About This Website

A Journey

During my career as an analyst-programmer, I worked with codes in a variety of contexts—writing software systems, designing algorithms for security applications, and developing modelling tools for business and finance. These systems were intricate, but ultimately finite and predictable, always bound to the rules of the development environments in which they were created.

Many decades ago, I found myself drawn toward a very different kind of information system: the ones that operated inside living organisms. Compared with the mechanical logic of commercial and technical systems, biological information proved to be many times more complex. Its rules were layered, its architecture unfamiliar, and its underlying logic harder to grasp.

The organic coding systems shared only a superficial resemblance to the computer codes I knew. Even their basic principles demanded more effort to understand than any programming challenge I had faced.

Yet the more I studied natural systems, the more compelling the mystery became. Each question generated others, and each deep dive branched into new lines of enquiry. It quickly became clear that these foundational sciences, particularly biology, contained far more questions than answers.

As this exploration unfolded, I began to notice something unexpected: The patterns discovered in molecular biology echoed patterns found throughout the cosmos. Patterns in the fields of physics, chemistry and cosmology displayed complexity shaped by symmetry, hierarchy, feedback systems, and finely balanced interdependent functions.

I examined the interaction of matter which behaved with grammar‑like precision; I marvelled at the fine calibration of gravity which, at gargantuan scales sculpted galaxies into coherent forms, and yet at micro scales it influenced essential fluid flow in our very cells and the required density of our bones; and at even smaller scales atoms assembled according to a wealth of strict rules or laws.

Across these fields, some scientists were describing the universe using informational or mathematical language. They examined the underlying principles governing matter, energy, and the essence of the universe, convinced that nature operated according to definable, structured laws that could be reduced to one tidy explanation.

One thing that puzzled me was the incongruity manifest in how these conclusions were applied. Some experts were comfortable describing the universe in terms of algorithms or mathematical codes, yet they hesitated to use similar terms for biological systems—even though our bodies’ cells managed information via symbols, sequences, and logic that I found extraordinarily impressive.

In other words, they could see structure in the stars but only randomness in the cell; coherence in the cosmos but chance in the genome.

This tension sparked some of the central questions of my journey:

Why was the universe allowed its architecture, but life was denied its code?
Why coherence for the cosmos, but randomness for life?
And what if both—the cosmos and the cell—reflected the same underlying principles of structured organisation?

It is in the shadows of those principles that The Code at the Dawn of Time emerged. It explores and correlates the most intricate and sometimes mind-blowing codes, patterns, and indelible threads of nature—revealing how, when viewed together, they cast a striking new light on the origins of life, structure, and time itself!

Contact me.

My wife Lin and me.

The fam.

References & Acknowledgements

Note: The references listed here, in addition to those explicitly given in the various articles herein, were consulted in the development of this website and in the material for the accompanying book.

https://people.csail.mit.edu/devadas/pubs/recomb11.pdf
Baron M. Main AL. Driscoll PC. Mardon HJ. Boyd J. Campbell ID. 1992. 1H NMR Assignment and Secondary Structure of the Cell Adhesion Type III Module of Fibronectin. 31: 2068-2073.
Baron M. Norman D. Willis A. Campbell ID. 1990. Structure of the Fibronectin Type I Module.
Barrow, G. M., The Structure of Molecules, W. A. Benjamin, 1963.
Bahcall, J. N., Phys. Rev. Letters 12, 300, 1964.
Beiser, Arthur, Concepts of Modern Physics, 5th Ed., McGraw-Hill, 1995.
Beiser, Arthur, Perspectives of Modern Physics, McGraw-Hill, 1969.
Ffrench-Constant C. 1995. Alternative Splicing of Fibronectin--Many Different Proteins but Few Different Functions. Exp. Cell. Res. 221: 261-271.
Harwit, Martin, Astrophysical Concepts, Springer-Verlag, 1988.
Kaufmann, William J. III, Universe, 3rd Ed., W. H. Freeman, (1991).
Rohlf, James William, Modern Physics from a to Z0, Wiley, 1994.
Gehris AL. Oberlender SA. Shepley KJ. Tuan RS. Bennett VD. 1996. Fibronectin mRNA Alternative Splicing is Temporally and Spatially Regulated During Chondrogenesis in Vivo and in Vitro. Develop. Dyn. 206: 219-230.
Main AL. Harve TS. Baron JB. Campbell ID. 1992. The Three-Dimensional Structure of the Tenth Type III Module of Fibronectin: An Insight into RGD-Mediated Interactions. Cell. 71: 671-678.
Potts JR and Campbell ID. 1994. Fibronectin Structure and Assembly. Curr. Cell Bio. 6: 648-655.
Potts JR and Campbell ID. 1996. Structure and Function of Fibronectin Modules. Matrix Bio. 15: 313-320.
Downie SA. Newman SA. 1995. Different Roles for Fibronectin in the Generation of Fore and Hind Limb Precartilage Condensations. Develop. Bio. 172: 519-530.
Brasnjevic, I., Hof, P.R., Steinbusch, H.W. & Schmitz, C. Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair (Amst.) 7, 1087–1097 (2008).
Moreira, P.I. et al. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44, 1493–1505 (2008)
Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883–891 (2004).
Bonner, W.M. et al. ?H2AX and cancer. Nat. Rev. Cancer 8, 957–967 (2008).
Ismail, I.H. & Hendzel, M.J. The ?-H2A.X: is it just a surrogate marker of double-strand breaks or much more? Environ. Mol. Mutagen. 49, 73–82 (2008).
Kim, D. et al. Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803–817 (2008).
Fernandez-Capetillo, O. et al. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. Dev. Cell 4, 497–508 (2003).
Lee, S.Y. et al. Histone XH2AX is required for Xenopus anterior neural development: critical role of threonine 16 phosphorylation. J. Biol. Chem. 285, 29525–29534 (2010).
Yin, B. et al. Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination. J. Exp. Med. 206, 2625–2639 (2009).
Fernando, R.N. et al. Cell cycle restriction by histone H2AX limits proliferation of adult neural stem cells. Proc. Natl. Acad. Sci. USA 108, 5837–5842 (2011).
Crowe, S.L., Movsesyan, V.A., Jorgensen, T.J. & Kondratyev, A. Rapid phosphorylation of histone H2A.X following ionotropic glutamate receptor activation. Eur. J. Neurosci. 23, 2351–2361 (2006).
Crowe, S.L., Tsukerman, S., Gale, K., Jorgensen, T.J. & Kondratyev, A.D. Phosphorylation of histone H2A.X as an early marker of neuronal endangerment following seizures in the adult rat brain. J. Neurosci. 31, 7648–7656 (2011).
Palop, J.J. et al. Vulnerability of dentate granule cells to disruption of Arc expression in human amyloid precursor protein transgenic mice. J. Neurosci. 25, 9686–9693 (2005).
Vazdarjanova, A. et al. Spatial exploration induces ARC, a plasticity-related immediate-early gene, only in calcium/calmodulin-dependent protein kinase II-positive principal excitatory and inhibitory neurons of the rat forebrain. J. Comp. Neurol. 498, 317–329 (2006).
Cheng, I.H. et al. Accelerating amyloid-ß fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J. Biol. Chem. 282, 23818–23828 (2007).
Palop, J.J. et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl. Acad. Sci. USA 100, 9572–9577 (2003).
Palop, J.J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697–711 (2007).
Palop, J.J. & Mucke, L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812–818 (2010).
Roberson, E.D. et al. Reducing endogenous tau ameliorates amyloid ß-induced deficits in an Alzheimer's disease mouse model. Science 316, 750–754 (2007).
Götz, J. & Ittner, L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532–544 (2008).
Kobayashi, D.T. & Chen, K.S. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav. 4, 173–196 (2005).
Marchetti, C. & Marie, H. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models? Rev. Neurosci. 22, 373–402 (2011).
Lange, J. et al. ATM controls meiotic double-strand-break formation. Nature 479, 237–240 (2011).
Fillingham, J., Keogh, M.C. & Krogan, N.J. ?H2AX and its role in DNA double-strand break repair. Biochem. Cell Biol. 84, 568–577 (2006).
Anderson, L., Henderson, C. & Adachi, Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell Biol. 21, 1719–1729 (2001).
Ward, I.M., Minn, K., Jorda, K.G. & Chen, J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 278, 19579–19582 (2003).
Olive, P.L. & Banath, J.P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23–29 (2006).
Flint, M.S., Baum, A., Chambers, W.H. & Jenkins, F.J. Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology 32, 470–479 (2007).
Harris, J.A. et al. Transsynaptic progression of amyloid-ß-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 68, 428–441 (2010).
Roberson, E.D. et al. Amyloid-ß/Fyn-induced synaptic, network, and cognitive impairments depend on Tau levels in multiple mouse models of Alzheimer's disease. J. Neurosci. 31, 700–711 (2011).
Verret, L. et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708–721 (2012).
Palop, J.J. & Mucke, L. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66, 435–440 (2009).
Morris, M., Maeda, S., Vossel, K. & Mucke, L. The many faces of tau. Neuron 70, 410–426 (2011).
Sanchez, P.E. et al. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc. Natl. Acad. Sci. USA 109, E2895–E2903 (2012).
Hardingham, G.E. & Bading, H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat. Rev. Neurosci. 11, 682–696 (2010).
Li, S. et al. Soluble Aß oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J. Neurosci. 31, 6627–6638 (2011).
Shull, E.R. et al. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23, 171–180 (2009).
Bhogal, N., Jalali, F. & Bristow, R.G. Microscopic imaging of DNA repair foci in irradiated normal tissues. Int. J. Radiat. Biol. 85, 732–746 (2009).
Grudzenski, S., Raths, A., Conrad, S., Rube, C.E. & Lobrich, M. Inducible response required for repair of low-dose radiation damage in human fibroblasts. Proc. Natl. Acad. Sci. USA 107, 14205–14210 (2010).
Canugovi, C. et al. Endonuclease VIII-like 1 (NEIL1) promotes short-term spatial memory retention and protects from ischemic stroke-induced brain dysfunction and death in mice. Proc. Natl. Acad. Sci. USA 109, 14948–14953 (2012).
Zhang, Y., Goodyer, C. & LeBlanc, A. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3,-6,-7, and -8. J. Neurosci. 20, 8384–8389 (2000).
Lee, H.G. et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochem. Int. 54, 84–88 (2009).
Li, L., Cheung, T., Chen, J. & Herrup, K. A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for death. Int. J. Alzheimers Dis. 2011, 171464 (2011).
Morris, M. et al. Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice. Neurobiol. Aging doi:10.1016/j.neurobiolaging.2012.12.003 (16 January 2013).
Cissé, M. et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47–52 (2011).
Li, S. et al. Soluble oligomers of amyloid ß-protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788–801 (2009).
Esposito, L. et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26, 5167–5179 (2006).
Yang, J.L., Tadokoro, T., Keijzers, G., Mattson, M.P. & Bohr, V.A. Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. J. Biol. Chem. 285, 28191–28199 (2010).
Day, J.J. & Sweatt, J.D. Epigenetic mechanisms in cognition. Neuron 70, 813–829 (2011).
Gräff, J., Kim, D., Dobbin, M.M. & Tsai, L.H. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol. Rev. 91, 603–649 (2011).
Cheng, J.S. et al. Collagen VI protects neurons against Aß toxicity. Nat. Neurosci. 12, 119–121 (2009).
Kravitz, A.V. et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466, 622–626 (2010).
Spink, A.J., Tegelenbosch, R.A.J., Buma, M.O.S. & Noldus, L.P.J.J. The EthoVision video tracking system—a tool for behavioral phenotyping of transgenic mice. Physiol. Behav. 73, 731–744 (2001).
Pong, K., Doctrow, S.R., Huffman, K., Adinolfi, C.A. & Baudry, M. Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons. Exp. Neurol. 171, 84–97 (2001).
Rong, Y., Doctrow, S.R., Tocco, G. & Baudry, M. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc. Natl. Acad. Sci. USA 96, 9897–9902 (1999).
Pinheiro, J., Bates, D., DebRoy, S., Sarkar, D. & R Development Core Team. nlme: linear and nonlinear mixed effects models. R package version 3.1-102 (2011).

Contact:

Mailto: Designomics@outlook.com